The thermodynamics of glycopeptide antibiotic dimerization have been studied by means of sedimentation equilibrium, using A82846B, vancomycin, ristocetin and complexes formed with several cell wall model peptides. These results indicate that vancomycin dimerization can be strongly promoted in two ways: i) stabilization of the antibiotic conformation in which the carbonyl group of residue three is on the back face of the molecule and ii) preferential interaction of the dimer with the lysine residue of A^JV'-diacetyl-lysyl-D-alanyl-D-alanine.
of present thermodynamicdata. A82846B is a naturally occurring glycopeptide isolated from Amycolatopsis orientalis1 5). Its chemical structure ( Fig. 1 ) is similar to that of vancomycin except that it contains two 4-L-epi-vancosamine moieties instead of one16). In vitro activity of A82846B is comparable to that ofteicoplanin, but it is two to five times more active than vancomycin16).
This paper deals with the thermodynamic characterization of the complexes formed between monomeric or dimeric glycopeptide antibiotics and cell wall modelpeptides. This information is of major importance in order to determine, to what extent, dimerization may correlate with an enhancement of affinity toward bacterial cell wall precursors or biological activity. The dimerization equilibrium constants of A82846B,and free and bound ristocetin and vancomycin are reported, as well as the thermodynamic parameters for ligand binding to either monomericand dimeric vancomycinand ristocetin. The thermodynamics of A82846Bcomplexa-tion with different peptides have been also determined and the partitioning of the energetic contributions (JG, AH, AS) to ligand binding is presented. In addition, the structures of free A82846B and its Ac2-L-Lys-D-Ala- A. Structure of A82846Bincluding the code used to designated XHNMRresonances.
B. Representation of the hydrogen bonding network of the dimer formed between two molecules of A82846Bwhen bound to
Ac2-L-Lys-D-Ala-D-Ala, following the scheme employed in reference 25.
Ligand residues are labeled at the Ha proton. The broken lines indicate the position of intermolecular hydrogen bonds.
D-Ala complex have been characterized in aqueous solution. The reported data are discussed, in order to evaluate how the structural differences influence the energetics of dimerization and of peptide binding. Finally, the previously proposed role of dimerization in the biological activity of these antibiotics and eremomycin1'7'17) is also discussed on the basis of present thermodynamic data.
Results
Sedimentation Equilibrium The dimerization constants of the free antibiotics and their complexes were directly determined by sedimentation equilibrium.
Dimerization of A82846B in 0.1 m phosphate buffer at pH 7.0 was quantitatively analyzed using antibiotic concentrations ranging from 1 jum to (Table 1) .
NMR Spectroscopy
The assignment of the XHNMRspectra of A82846B
and A82846B/Ac2-Lys-D-AIa-D-Ala complex was carried out mainly from data of two-dimensional experiments (COSY, TOCSY, NOESY and ROESY) at pH 4.3 in aqueous solution. The letter code used to identify each Table 1 . Equilibrium dimerization constants for A82846B, vancomycin and ristocetin by sedimentation equilibrium in 0.1 m sodium phosphate buffer pH 7.0. proton in the antibiotic moiety is shown in Fig. 1 . Alal (or Al) and Ala2 (or A2) refers to the alanine residues at the C-terminal and intermediate position of the ligand, respectively. An exhaustive analysis of data at pH2.5 was also necessary to observe all exchangeable protons.
The proton spectra of A82846B/Ac2-L-Lys-D-Ala-D-Ala complex show the presence of two conformational forms, A and B, in an approximate ratio of 1 : 1 (see Fig.   2 ), which were completely identified on the basis of non-overlapping cross-peaks of the two species on the 2D-experiments. Temperature coefficients of amide protons, a(ppb/K), were calculated in the range 5~25°C at pH 4.3 for A82846B/Ac2-L-Lys-D-Ala-D-Ala complex and at pH 2.5 for free A82846B. Proton chemical shifts and temperature coefficients are summarized in Table 2 .
In both free and complexed forms, the assignment of the peptide backbone protons in H2Owas achieved following the well-established sequence-specific methodology18). Spins systems were identified from phase- A and B refer to conformer A or B, respectively. The titration of A82846B with Ac-D-Ala and the dipeptides was carried out using both calorimetric and spectrophotometric techniques. Fig. 4 shows the calorimetric titration curves, normalized to kJ per mol of antibiotic dimer. The experimental results were analyzed in order to derive both the enthalpy change and the binding constants, as previously described13). The saturation fraction is well described assuming two identical sites for peptide binding in the dimer. Solid lines in Fig. 4 correspond to the theoretical fits of the experimental data using the thermodynamic parameters reported in Table 3 , expressed per mole of binding site.
The association constants derived from spectrophotometric curves were in good agreement with those derived from calorimetric curves. The binding constant for the 
The curves were calculated by the use of the thermodynamic parameters reported in Table 3 .
mined from spectrophotometric titration curves and the enthalpy change of complexation was determined by using saturating Ac2-Lys-D-Ala-D-Ala concentrations.
The thermodynamic parameters for the tripeptide complex formation are presented in Table 3 .
Discussion
Structure of Dimeric A82846B In agreement with the high dimerization constant calculated above, signals of monomeric A82846B in the XHNMRspectra were not observed. In addition to NOEswhich define the three-dimensional structure of A82846B backbone (free and complexed), the NOEs arising from the dimeric structure of the antibiotic were also observed (see Table 4 and Fig.  2 NOESYspectra). These NOEs, together with data provided by temperature coefficients (see Table 2 ), indicate that the dimer which was formed had the same hydrogen bond-network as that proposed for ristocetin and eremomycin (see Fig. 1 )6). The low temperature coefficient of W5in both free and complexed A82846B confirmed its implication in dimer formation. Proton w6 was also expected to be hydrogen bonded to the opposite (CO)3 group, and a low temperature coefficient was found in both complexed forms. However, due to Ac
The subscripts M and D refers to monomeric or dimeric species, respectively, and AXappis the experimental magnitude. a zlXapp are from references 6d and 8; unless otherwise stated vancomycin concentration was 300^m. b>c Experimental values determined at vancomycin concentrations of 127 and 22 um, respectively. 
Abbreviations: S, Strong; W, weak.
the lack of data of w6 in the free antibiotic, it is not possible to demonstrate that this proton was involved in antibiotic dimerization rather than in peptide binding. In addition to the NOEs reported for ristocetin and eremomycin, two weak NOEs between, 2b and Me3(V/), and, x2 and 2'(V') were observed in both conformers of complexed A82846B. Moreover, a NOEbetween 2e and Me3(V/) was found only in conformer A.
The NOEswhich define the backbone structure of the Af-terminal part of the antibiotic (in particular NOEs between NH2(Asn) and cc'; 3aa'and aa and 3aa'and cc') are the same for both free and complexed A82846B. These results and the low temperature coefficients found for w2, w3 and w4 protons in the free antibiotic suggest a closed conformation for this part of the molecule.
Structure of the Complex
The binding of Ac2-Lys-D-Ala-D-Ala caused extensive shielding effects on some parts of the A82846Bmolecule in comparison to the free antibiotic (see Table 2 ). The set of intermolecular NOEs, defining the structure of the complex in aqueous solutions (see Table 5 ), and the temperature coefficients observed for the NHproton of 187 Ala 1, w2, w3, w4 and w7, show that the main structural features are very similar to those previously reported for vancomycin and ristocetin (Fig. I) 8" 11*. Nevertheless, some important differences are observed concerning the interactions established through the TV-terminal Nmethylleucine, the sugar moiety attached to residue 4 and the Ac2-lysine residue of the tripeptide. Qualitative evaluation of all NOEs involving Ala-1 protons confirm its proximity to residue 1 and the aromatic ring of 2. These NOEsare somewhat different from those found in vancomycin, but are coincident with the results reported for TVjTV'-diacetyrvancomycin/ Ac2Lys-D-Ala-D-Ala.20) They suggest that the 7V-methylleucine side chain folds in the direction of the Alal residue binding site, providing an extended hydrophobic wall to the carboxylic pocket. The location of the Ala2 residue is defined by a strong NOE between Me-Ala2 and the aromatic proton 5b (see NOESYspectra in Fig. 2 ) and other lower intensity NOEswith aromatic protons of residue 7, x5 and x6. No NOEs were found between this residue and the TV-terminal region of the antibiotic. The location of the Lys residue in A82846B complex is denned by the NOEs 6b<-*NHa-Lys and 6b<-> (CH3CO)a, and also several NOEsof (CH3CO)a with This observation could be related with the dissimilarities of ristocetin and A82846Bor vancomycin dimerization upon tripeptide binding.
Conformational Equilibrium of A82846B-tripeptide Complex The NMRstudies showed that, the three-dimensional structure of the antibiotic moiety and the interactions with the tripeptide, are very similar in both A and B conformations (see Table 5 ). The largest differences were observed in the sugar portion attached to ring 4 (V and THE JOURNAL OF ANTIBIOTICS dimerization observed from acid to neutral pH, since the carbonyl (CO)3 is involved in two of the four hydrogen bonds formed between the back faces of the two molecules in the dimer (Fig. 1) . According to this, cell-wall analogues should also enhance dimerization since they bind selectively to this vancomycin conformer. At neutral pH, dimerization of Ac-D-Ala-D-Ala/vancomycin was just two times higher than the free antibiotic, but Ac2-Lys-D-Ala-D-Ala binding increases vancomycin dimerization by two orders of magnitude. In contrast, at pH 5.0, vancomycin dimerization in the presence of the tripeptide increases by three orders of magnitude.
These results suggest that, at neutral pH, most of the vancomycin molecules could already have adopted the right conformation for peptide binding. Furthermore,
they also indicate either a preferential interaction of the lysine residue with dimeric vancomycin, or the induction of a conformational change in the antibiotic leading to a more suitable conformation for dimer formation. The stronger effect of Ac2-Lys-D-Ala-D-Ala at pH 5.0 would reflect both the induction of the vancomycin conformer with the (CO)3 group at the back of the molecule and the preferential interaction with lysine. These results would explain the observed aggregation of cell wall fragments induced by vancomycin7). The influence of tripeptide binding on vancomycin dimerization has not been described so far and was comparable to the reported effect of this ligand on eremomycin, MM4 7761 and A82846B dimerization at pD 3.71}. The dimerization constant ofA82846B at pH 7.0 was of an order of greater magnitude than the value calculated by NMR,using hydrogen-deuterium exchange rates at pD 3.725). This difference was consistent with the influence of pH on vancomycin dimerization (see Table 1 ). Taking into account the experimental conditions employed for binding studies13'14) and the dimerization constants of free and complexed vancomycin, the free energy change contributed by dimerization to the experimental AGvalues can be estimated to be -2.4kJà"
for Ac2-Lys-D-Ala-D-Ala binding and -2.5kJ-(mol monomer)"1 for Ac-D-Ala and the dipeptides. Analogously, using the reported dimerization enthalpies1'7'27^AU2 and AH\, the contribution of vancomycin dimerization to the apparent enthalpy change was estimated in -llkJ-mol monomer"1for the tripeptide and -3 kJ-mol monomer"1 for the other ligandsn. The estimated thermodynamic parameters for cell wall analogue binding to monomeric and dimeric vancomycin are shown in Table 3 . The stabilization of Ac-D-Ala/ and dipeptide/vancomycin complexes by dimerization is of enthalpic origin. In the case of the tripeptide both the enthalpy and the entropy changes contribute to enhance its binding to the dimeric vancomycin.
Partitioning of Energetic Contributions
to Ligand Binding The complexes of A82846B with Ac-D-Ala or the dipeptides are, in general, more stable than those of f The apparent linkage free energy change coupling ligand binding to antibiotic dimerization is AGUnkage=AG^-AG2,where AG\ and AG2are the dimerization free energy changes of the bound and free antibiotics, respectively. The free energy change of ligand binding to the dimer is zlGD=zlGM+ 1/2^Glinkage.
ft The apparent binding constant is
where KMand KDare the binding constant to the monomerand dimer (KD = KM(K2/K2)1/2). The free concentration ofmonomer vancomycin (see Table 3 ). Their free energy changes are very close to those found for ristocetin13'14) and about 2kJ-mol~1 lower than those of teicoplanin13). The present thermodynamic results indicate that differences between peptide-antibiotics interactions in either A or B conformations of A82846Bshould be minor, since all the binding sites were found to be identical, within experimental error.
The comparison, between AG values for dimeric vancomycin and A82846B, shows that, the sugar moiety on residue 6 (V) stabilizes the binding of Ac-D-Ala, Ac-Gly-D-Ala and Ac-D-Ala-D-Ala by about -4kJ-mol"1;
Ac-D-Ala-Gly binding is stabilized only by -3kJ-mol~1 and V opposes tripeptide binding by 2.6 kJ à"mol" 1. Although the intrinsic affinity of the A82846B dimer for the tripeptide is about 3 kJ à"mol~x higher than that of the vancomycin monomer, tripeptide binding to dimeric vancomycin is more favorable than it is to the A82846B dimer. Table 6 shows the variations observed in the thermodynamic parameters of peptide binding when one amino acid is added or changed in the bonding peptide. Taking into account the low influence of ligand binding on ristocetin dimerization, the reported values should be representative of peptide binding to both association states. The differences found in the energetics of peptide binding to A82846B by substitution of alanine for glycine, or peptide chain elongation, resemble more those found for ristocetin or teicoplanin (see Table 6 ), despite the closest structural relationship between A82846B and vancomycin.
The free energy of Ac-d-Ala binding to dimeric vancomycin is about 5kJà"mol~1 less favorable than to FEB. 1996 A82846B. Halfofthis value is composed of contributions from differences in hydrophobic interactions with the antibiotic due to Me-Ala1 (Table 6) Table 6 . Differences in the thermodynamics of antibiotic-peptide binding, generated by modification or addition of one amino acid in the bonding peptidea.
-AAG QJ/mol) NOEs of (CH3CO-NH)aof lysine with several protons of the epi-vancosamine sugar V, suggest the proximity between them. Taken into account the structural similarities between A82846B and vancomycin, the epi-vancosamine residue V opposes lysine-A82846B interactions by 7.7kJ-mol"1.
The different affinities of A82846B and eremomycin for Ac2-Lys-D-Ala-D-Alal, 25'29) could be attributed to the chlorine atom on ring 6. The NOEsof(CH3CO-NH) of lysine with protons 6b, z6 and several protons of the epi-vancosamine sugar V, suggest the proximity between ring 6 and this residue.
Antibiotic Dimerization and Biological Activity A82846Bis two to five times more active than vancomycin. Eremomycin (the monochloride derivative on amino acid 2 of A82846B), is as active as A82846B in vitro and both have very high dimerization constants25). The affinity of eremomycin for Ac2-Lys-D-Ala-D-Ala is about 20 fold lower ('~7.4kJ-mol~1,) in terms of the binding constant, than that of A82846B29). This lack of correlation between efficacy and affinity towards Ac2-Lys-D-Ala-D-Alaof eremomycin and the effect of low Ac2-Lys-D-Ala-D-Ala concentrations on its antibacterial activity, leads to the proposal that, the efficacy of this antibiotic may be derived from the formation of dimers29). In the present study, no cooperativity has been observed between the two binding sites of dimeric A82846B. The slopes of the Hill plots yield values very close to unity30) for all the peptides tested. Nevertheless, "in vivo" and assuming that the cell wall precursors were locally concentrated, saturation of the second binding site would be an intramolecular process. This would increase its free energy change by at least -lOkJ-mol"1 (the cratic term contributed by the entropy of mixing31}). However, it remains unclear why antibacterial activities of A82846Band eremomycin became unaffected by their differences in affinity, since both form stable dimers at very low concentrations. Recently, the higher tendency of eremomycin, over A82846B, to form dimers has been considered as a plausible explanation for this anomalous behavior1'25).
However, at neutral pH about 75% of free A82846B is a dimer at an antibiotic concentration as low as 1 /lim and this quantity increases up to 99% upon Ac2-Lys-DAla-D-Ala binding1'25^These values, and the free energy change contributed by the linkage between the binding Lys-D-Ala-D-Ala) were purchased from Sigma Chemical Co. All other chemicals were of analytical grade. A82846B (LY264826B) was a gift from Eli Lilly Co., Indianapolis, U.S.A., vancomycin was obtained from Sigma Chemical Co. and ristocetin A was from Lundbeck, Copenhagen, Denmark. All the antibiotics were used without further purification. Antibiotic concentrations were measured spectrophotometrically by employing the absorption coefficients reported elsewhere32~34).
NMR Spectroscopy
Free A82846B and (1 : 1) A82846B-tripeptide complex were dissolved in 0.5ml of either D2Oor 90% H2O/10% D2O leading to 1.1mM solutions.
XHNMRspectra were recorded at pH 4.3 and pH 2.5 on a BRUKER AMX-600 spectrometer at different temperatures from 5 to 65°C, at intervals of 10°C. Sodium 3-trimethylsilyl (2,2,3,3-2H4) propionate (TSP) was used as the internal reference. Two-dimensional spectra COSY, 35) TOCSY,36) NOESY38) and ROESY37) were performed on both D2Oand H2Osamples. All spectra were recorded in the phase sensitive mode using the time proportional mode39) and presaturation of the solvent signal: The carrier frequency was placed on the H2Oor
HOD resonance frequency for each temperature, and typical 512 experiments were collected, each containing 2048 data points. NOESYand ROESYspectra were recorded with mixing times of 300 and 200ms, respectively.
Microcalorimetric Measurements
Calorimetric titrations were carried out at 25°C with a LKB microcalorimeter equipped with a titration assembly (LKB 2107-350) .
The amplified output voltage-time curves were integrated by a micro-processor and monitored by a potentiometric recorder. The calorimeter was calibrated as described previously40). The results were corrected for small differential effects due to compression, mixing and dilution, which were determined in separate control experiments. At least three independents sets of measurements were performed for all the antibiotic-peptide complexes studied. The experiments were performed in 0. 1 m sodium phosphate buffer at pH 7.0, using antibiotic concentrations of about 250 fiM.
Spectrophotometric Measurements
U.V. measurements were carried out in a Cary 210 spectrophotometer equipped with thermostatically controlled cells. All the measurements were done in a differential form, with dilute solutions of the antibiotic (24jUM in 0.1 M-sodium phosphate buffer, pH 7.0 at 25°C) and matched cells with 1 cm pathlength. The temperature was kept constant at ±0.1°C. The accuracy in absorbance was +0.0005 units. Difference absorption spectra were recorded from 360 to 230nm. Equilibrium constants were calculated from the change in absorbance of the antibiotic spectrum generated by peptide binding13). At least two different wavelengths between 290 and 240 nm were employed.
Sedimentation Equilibrium Experiments
Sedimentation equilibrium measurements of A82846B (10~6 to 10"3m), vancomycin (10~5 to 10"3m, +/-Ac-D-Ala-D-Ala and tripeptide), and ristocetin (10~4 to 10"3m, +/-tripeptide) in 0.1m sodium phosphate buffer, were performed at 25°C by centrifuging SOfA samples at 40,000rpm in an Optima XL-A analytical ultracentrifuge (Beckman Instruments, Inc.). 12mm double sector centerpieces of epon-charcoal were employed. After equilibration, radial scans of the samples were taken at 1 hour intervals, at different wavelengths (240, 280, and 300nm) . Ligand concentrations were such that the glycopeptide remained more than 95%
complexed. In order to obtain the equilibrium dimerization constants (K2 and K2 for free and bound antibiotics), the experimental data for each antibiotic were simultaneously analyzed using the ORIGIN version of the NONLINalgorithm41}, with the standard deviation of the absorbance readings as a weighing factor. The monomer molecular mass (in daltons) were constrained to the following: 1590 (A82846B), 1447 (vancomycin), 2066 (ristocetin). The partial specific volumes, calculated FEB. 1996 from aminoacid and sugar composition,42) were 0.690 (A82846B, vancomycin) and 0.680 cm3/g (ristocetin).
